3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Ovarian Neoplasms
12
Peritoneal Neoplasms
9
Stomach Neoplasms
8
Neoplasm Metastasis
7
Colorectal Neoplasms
7
Fallopian Tube Neoplasms
5
Endometrial Neoplasms
5
Triple Negative Breast Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Squamous Cell Carcinoma of Head and Neck
3
Rectal Neoplasms
3
Neoplasms
3
Melanoma
3
Esophageal Neoplasms
3
Uterine Neoplasms
2
Urinary Bladder Neoplasms
2
Pseudomyxoma Peritonei
2
Pancreatic Neoplasms
2
Lung Neoplasms
2
Gestational Trophoblastic Disease
2
Cholangiocarcinoma
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Appendiceal Neoplasms
2
Vipoma
1
Uterine Cervical Neoplasms
1
Teratoma, Ovarian
1
Somatostatinoma
1
Interventions
Cisplatin
180
Radiotherapy
81
Paclitaxel
80
Brachytherapy
74
Carboplatin
72
pembrolizumab
63
Bevacizumab
40
Surveys and Questionnaires
29
Colposcopy
29
Radiation
28
Gemcitabine
28
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
27
Topotecan
26
Magnetic Resonance Spectroscopy
24
Blood Specimen Collection
23
human papillomavirus vaccine, L1 type 16, 18
22
Nivolumab
22
Drug Therapy
21
Papillomavirus Vaccines
20
atezolizumab
19
Platinum
19
Radiotherapy, Intensity-Modulated
18
Biopsy
18
Docetaxel
17
Taxes
16
Cyclophosphamide
16
Early Intervention, Educational
15
1,2-diaminocyclohexaneplatinum II citrate
15
Methods
14
fludarabine
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Leucovorin
×
Gynecologic
×
Clear all
NCT05891171
2026-03-31
ARC-25
Arcus Biosciences, Inc.
Phase 1
Active not recruiting
40 enrolled